Atlas Trials

Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients

Clinical trial NCT06882551 · COMPLETED

Trial details

NCT number
NCT06882551
Sponsor
Khyber Teaching Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Macular Edema (DME)
Start date
2023-04-01
Primary completion
2023-11-30
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.